Affiliation:
1. Unidad de Genética Bacteriana, Centro Nacional de Microbiología and Ciber Enfermedades Respiratorias, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain
Abstract
ABSTRACT
The low prevalence of ciprofloxacin-resistant (Cp
r
)
Streptococcus pneumoniae
isolates carrying recombinant topoisomerase IV genes could be attributed to a fitness cost imposed by the horizontal transfer, which often implies the acquisition of larger-than-normal
parE
-
parC
intergenic regions. A study of the transcription of these genes and of the fitness cost for 24 isogenic Cp
r
strains was performed. Six first-level transformants were obtained either with PCR products containing the
parC
quinolone resistance-determining regions (QRDRs) of
S. pneumoniae
Cp
r
mutants with point mutations or with a PCR product that includes
parE
-QRDR-
ant
-
parC
-QRDR from a Cp
r
Streptococcus mitis
isolate. The latter yielded two strains, T6 and T11, carrying
parC
-QRDR and
parE
-QRDR-
ant
-
parC
-QRDR, respectively. These first-level transformants were used as recipients in further transformations with the
gyrA
-QRDR PCR products to obtain 18 second-level transformants. In addition, strain Tr7 (which contains the GyrA E85K change) was used. Reverse transcription-PCR experiments showed that
parE
and
parC
were cotranscribed in R6, T6, and T11; and a single promoter located upstream of
parE
was identified in R6 by primer extension. The fitness of the transformants was estimated by pairwise competition with R6 in both one-cycle and two-cycle experiments. In the one-cycle experiments, most strains carrying the GyrA E85K change showed a fitness cost; the exception was recombinant T14. In the two-cycle experiments, a fitness cost was observed in most first-level transformants carrying the ParC changes S79F, S79Y, and D83Y and the GyrA E85K change; the exceptions were recombinants T6 and T11. The results suggest that there is no impediment due to a fitness cost for the spread of recombinant Cp
r
S. pneumoniae
isolates, since some recombinants (T6, T11, and T14) exhibited an ability to compensate for the cost.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献